Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Feb;300(2):G327-33.
doi: 10.1152/ajpgi.00422.2010. Epub 2010 Nov 25.

Importance and regulation of the colonic mucus barrier in a mouse model of colitis

J Petersson  1 , O Schreiber, G C Hansson, S J Gendler, A Velcich, J O Lundberg, S Roos, L Holm, M Phillipson
Affiliations

Importance and regulation of the colonic mucus barrier in a mouse model of colitis

J Petersson et al. Am J Physiol Gastrointest Liver Physiol. 2011 Feb.

Abstract

The colonic mucus layer serves as an important barrier and prevents colonic bacteria from invading the mucosa and cause inflammation. The regulation of colonic mucus secretion is poorly understood. The aim of this study was to investigate the role of the mucus barrier in induction of colitis. Furthermore, regulation of mucus secretion by luminal bacterial products was studied. The colon of anesthetized Muc2(-/-), Muc1(-/-), wild-type (wt), and germ-free mice was exteriorized, the mucosal surface was visualized, and mucus thickness was measured with micropipettes. Colitis was induced by DSS (dextran sodium sulfate, 3%, in drinking water), and disease activity index (DAI) was assessed daily. The colonic mucosa of germ-free and conventionally housed mice was exposed to the bacterial products LPS (lipopolysaccharide) and PGN (peptidoglycan). After DSS induction of colitis, the thickness of the firmly adherent mucus layer was significantly thinner after 5 days and onward, which paralleled the increment of DAI. Muc2(-/-) mice, which lacked firmly adherent mucus, were predisposed to colitis, whereas Muc1(-/-) mice were protected with significantly lower DAI by DSS compared with wt mice. The mucus barrier increased in Muc1(-/-) mice in response to DSS, whereas significantly fewer T cells were recruited to the inflamed colon. Mice housed under germ-free conditions had an extremely thin adherent colonic mucus layer, but when exposed to bacterial products (PGN or LPS) the thickness of the adherent mucus layer was quickly restored to levels observed in conventionally housed mice. This study demonstrates a correlation between decreasing mucus barrier and increasing clinical symptoms during onset of colitis. Mice lacking colonic mucus (Muc2(-/-)) were hypersensitive to DSS-induced colitis, whereas Muc1(-/-) were protected, probably through the ability to increase the mucus barrier but also by decreased T cell recruitment to the afflicted site. Furthermore, the ability of bacteria to regulate the thickness of the colonic mucus was demonstrated.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
The adherent mucus layer in wild-type mice decreased whereas disease activity index increased with days on dextran sulfate sodium (DSS). A: adherent mucus thickness (μm) in wild-type (C57Bl/6) mice without (untreated, n = 11) or with 3% DSS addition to the drinking water for 6–8 days (n = 9). B: disease activity index of the mice treated with DSS (solid lines) and the decreasing mucus thickness at different time points during DSS treatment (open bars) (n = 27). C and D: histological tissue sections stained with hematoxylin-eosin from untreated and DSS-treated C57Bl/6 mice, respectively. *P < 0.05; bars correspond to 100 μm.
Fig. 2.
Fig. 2.
Muc2-deficient mice lack adherent colonic mucus and develop a more severe colitis. Disease activity index in wild-type (wt; n = 8) and Muc2-deficient mice (n = 5) before (A) and 2–4 days following DSS treatment (B). C: adherent mucus thickness (μm) of untreated (n = 9) and DSS-treated Muc2-deficient mice (n = 5). Please note that the DSS treatment had to be interrupted already after 2–4 days because of severe rectal bleeding and weight loss in Muc2-deficient mice. D and E: histological samples stained with periodic acid-Schiff (PAS) from untreated and DSS-treated Muc2-deficient mice, respectively. F: bacterial penetrations estimated by bacterial culturing of spleens isolated from DSS-treated wt (n = 2) or Muc2−/− mice (n = 2). *P < 0.05; bars correspond to 100 μm.
Fig. 3.
Fig. 3.
Muc1-deficient mice are partly protected against DSS colitis by increased adherent mucus thickness and decreased T cell infiltration. A: adherent colonic mucus thickness (μm) in Muc1-deficient mice with (n = 7) or without (n = 7) DSS treatment for 6–8 days. B: disease activity index in wild-type (n = 9) or Muc1-deficient mice (n = 7) after DSS treatment. *P < 0.05. C and D: representative histological samples stained with hematoxylin-eosin from Muc1-deficient mice with or with DSS treatment. E: immunohistological staining with an anti-CD3 mAb (as indicated by arrows) and quantification of infiltrated T cells in the DSS-treated wild-type (n = 3) or Muc1-deficient (n = 5) colonic mucosa (number of infiltrated T cells per mm2 colonic mucosa). Significantly fewer T cells were observed in the mucosa of Muc1−/− mice. Bars correspond to 100 μm.
Fig. 4.
Fig. 4.
Germ-free mice lack firmly adherent colonic mucus, but this mucus layer is restored by bacterial products. A and B: thickness of the adherent mucus in the colon in NMRI mice housed conventionally (n = 9) or under germ-free conditions (n = 11) either with luminal saline or the bacterial products LPS (conventional; n = 5, germ-free; n = 7) or peptidoglycan (PGN; conventional; n = 4, germ-free; n = 4). The mucus thickness is expressed in μm; *P < 0.05. C and D: representative histological samples from a conventional and a germ-free mouse stained with PAS solution. Arrows point at PAS-stained mucins. Bars correspond to 100 μm.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Abreu MT. Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function. Nat Rev Immunol 10: 131–144, 2010 - PubMed
    1. Ahn DH, Crawley SC, Hokari R, Kato S, Yang SC, Li JD, Kim YS. TNF-alpha activates MUC2 transcription via NF-kappaB but inhibits via JNK activation. Cell Physiol Biochem 15: 29–40, 2005 - PubMed
    1. Atuma C, Strugala V, Allen A, Holm L. The adherent gastrointestinal mucus gel layer: thickness and physical state in vivo. Am J Physiol Gastrointest Liver Physiol 280: G922–G929, 2001 - PubMed
    1. Backert S, Selbach M. Role of type IV secretion in Helicobacter pylori pathogenesis. Cell Microbiol 10: 1573–1581, 2008 - PubMed
    1. Backhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI. Host-bacterial mutualism in the human intestine. Science 307: 1915–1920, 2005 - PubMed

Publication types

MeSH terms